Back
AVITA Medical, Inc. 10K Form
Sell
24
RCEL
AVITA Medical, Inc.
Last Price:
$4.79
Seasonality Move:
0.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RCEL News And Ratings
See the #1 stock for the next 7 days that we like better than RCEL
RCEL Financial Statistics
Sales & Book Value
| Annual Sales: | $71.6M |
|---|---|
| Cash Flow: | $-4.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.54 |
| Price / Book: | 40.83 |
Profitability
| EPS (TTM): | -1.75100 |
|---|---|
| Net Income (TTM): | $-48.6M |
| Gross Margin: | $58.8M |
| Return on Equity: | -1112.54% |
| Return on Assets: | -74.17% |
AVITA Medical, Inc. Earnings Forecast
Key AVITA Medical, Inc. Financial Ratios
-
The Gross Profit Margin over the past 28 years for RCEL is 82.13%.
-
The Selling, General & Administrative Expenses for RCEL have been equal to 112.43% of Gross Profit Margin.
-
The Research & Development expenses have been 29.10% of Revenue.
-
The Net Earning history of RCEL is -67.85% of Total Revenues.
-
Per Share Earnings over the last 33 years have been positive in 14 years.
AVITA Medical, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RCEL |
| Website: | avitamedical.com |
Debt
| Debt-to-Equity Ratio: | -2.77 |
|---|---|
| Current Ratio: | 0.57 |
| Quick Ratio: | 0.44 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 11.18 |
RCEL Technical Analysis vs Fundamental Analysis
Sell
24
AVITA Medical, Inc. (RCEL)
is a Sell
Is AVITA Medical, Inc. a Buy or a Sell?
-
AVITA Medical, Inc. stock is rated a SellThe current AVITA Medical, Inc. [RCEL] share price is $4.38. The Score for RCEL is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.